InvestorsHub Logo
Followers 48
Posts 2645
Boards Moderated 0
Alias Born 12/19/2015

Re: ROS-CH post# 685080

Sunday, 04/14/2024 9:40:00 AM

Sunday, April 14, 2024 9:40:00 AM

Post# of 688904
LP has complete control and she knows what this platform technology is worth. True value likely wasn’t offered prior to JAMA peer-reviewed article with 70+ internationally respected physicians and scientist co-authors. LP saw commercial approval in sight after JAMA publication. Why do a deal when you’re weeks away from commercial approval. Better to wait until approval then the price goes way up and patients are guaranteed the treatment. Game, set, match.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News